INSIGHTS ON PHARMACEUTICAL PACKAGING

• FAQs On The Revised EU GMP Annex 1: Volume 2

  Review the implementation of a holistic Contamination Control Strategy (CCS). Discover four key considerations for assessing component readiness: product, process, protection, and proof.

• Improve Speed To Market By Mitigating Vial And Stopper Incompatibility

  These studies indicate that with a properly assembled vial containment system, good CCI performance can be achieved with stoppers of a given elastomer, independent of configuration/size, or vial style.

• Methods For Determining Equipment Capability Of Freeze-Dryers

  Observe two experimental methods for determining choked flow: the minimum controllable pressure method and the choke point method.

• Effective Procurement Strategies For Labeling Systems In Drug Manufacturing

  What is actually behind the procurement of a pharmaceutical labeling machine and how does the process work? You can find out here what the path to your pharmaceutical labeling machine looks like.

• Bringing A Biosimilar For Oncology To Market: Injectable Packaging From Early Development To Commercialization

  2/20/2024

  While in their early-stage development of a mAb biosimilar for oncology treatment, a large biopharmaceuticals company sought a packaging recommendation: a stopper to maintain high-quality standards.

• Understanding Injectable Drug Container Closure Systems

  6/20/2024

  Choosing the right container closure system (CCS) format is crucial, so understanding the different parts involved, their functions, storage requirements, and how they impact administering the drug is essential.

• The Rising Need For Flexibility In Blister Packaging For CDMOs And Drug Manufacturers

  8/1/2024

  In the pharmaceutical industry, processes are subject to continuous change due to evolving requirements and regulations. Consequently, pharmaceutical companies and contract packagers often require adaptable packaging solutions, such as blister machines, to meet these dynamic needs.

• How DFM Promotes Scalability, Repeatability, And Profitability

  6/28/2024

  Find out why it is critical that OEMs see and understand the benefits of taking time to build a mold or create automation more robustly to achieve long-term savings and higher annual production.

• Innovation For Subcutaneous Delivery Of Large-Volume Complex Biologics

  5/9/2024

  Explore the key findings of a new wearable injector clinical trial, including its positive impact on patient experience and the broader benefits of wearable injectors for chronic disease management.